Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which nasal pack is kinder to your nose after surgery?

NCT ID NCT07560254

Symptom relief Sponsor: Ayu, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two different nasal packs used after nose surgery to see which one patients liked better and which led to better healing. Twenty adults who had nasal surgery received either a VELNEZ or NASOPORE pack. Researchers checked for pain, bleeding, and how well the pack broke down over 90 days.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
VELNEZ Nasal Pack (biodegradable composite of gelatin, chitosan, polyvinyl alcohol, and psyllium husk) and NASOPORE Nasal Pack (biosynthetic biodegradable polyurethane foam)
What this could lead to
If VELNEZ works better, it could offer patients less pain and faster healing after nasal surgery.
What could go wrong
This is a very small study (20 people) at one center, so results may not apply to everyone. The packs are already approved, so no major new breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Sep 2024

Finished

Jul 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants eligible for the use of a nasal pack (either VELNEZ or Nasopore) in routine clinical practice after a planned nasal surgery. * Male and female in the age group of 18 to 70 years. (Both Included) * Participants or their LAR who can provide informed consent form in writing. * Participants who allow their study data to be collected at pre-defined follow-up period. Exclusion Criteria: Participants who are unable to be treated with VELNEZ, or Nasopore nasal pack in routine clinical practice after a planned surgery. * Participant's/ legal guardian (LAR) who cannot provide informed Consent written. * Participant unwilling or unable to comply with the postoperative visits necessary for data collection. * Participant with an active infection at the surgery site. * Participant with a history of asthma. * Pregnant or lactating Females * Participant who are on aspirin or anti-platelet drugs therapy. * Participant positive for HIV, HCV, VDRL, HBs Ag. * Participant who is allergic (Hypersensitive) to any of the ingredients of the nasal packs. * Participant with bleeding disorders. * Any medical condition that, in the opinion of the investigator, would make the subject unsuitable for inclusion (e.g., a chronic, relapsing or hereditary disease that may interfere with the outcome of the study).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic rhino-sinusitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic rhinosinusitis Rhinosinusitis sinusitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic rhino-sinusitis Rhinosinusitis Sinusitis

Contacts and locations

Locations

  • Hospital Al-Sultan Abdullah, Universiti Teknologi MARA, Jalan Hospital, UiTM Sungai Buloh Campus

    Sungai Buloh, Selangor, 47000, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.